Literature DB >> 7020609

Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands.

I D Riley, F A Everingham, D E Smith, R M Douglas.   

Abstract

In Tari, in the southern highlands of Papua New Guinea, each child experienced, on average, two acute lower respiratory tract infections (ALRTI) between birth and age 5 years. The yearly mortality rate from ALRTI was 30 per 1000 in infants, and 4 per 1000 in children aged between 1 and 4 years. A double-blind trial of a 14-valent pneumococcal polysaccharide vaccine was carried out on 871 children from this community who were aged between 6 months and 5 years. Morbidity from ALRTI was lower (by 37%) in children given the vaccine provided they were at least 17 months of age at the time of immunisation. There were 8 deaths from ALRTI in the placebo group, but only 1 death in the vaccine group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020609      PMCID: PMC1627425          DOI: 10.1136/adc.56.5.354

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants.

Authors:  J M Borgoño; A A McLean; P P Vella; A F Woodhour; I Canepa; W L Davidson; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-01

2.  Polyvalent pneumococcal polysaccharide vaccines.

Authors:  M R Hilleman; A A McLean; P P Vella; R E Weibel; A F Woodhour
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

3.  Some observations on the communicable diseases as public health problems.

Authors:  W C Cockburn; F Assaad
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  Acute respiratory infections: a review.

Authors:  A Bulla; K L Hitze
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

5.  Pneumonia in a Navajo community: a two-year experience.

Authors:  R Oseasohn; B E Skipper; B Tempest
Journal:  Am Rev Respir Dis       Date:  1978-06

6.  Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.

Authors:  I D Riley; P I Tarr; M Andrews; M Pfeiffer; R Howard; P Challands; G Jennison
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

  6 in total
  7 in total

Review 1.  Pneumococcal vaccine.

Authors:  R T White
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

2.  New bacterial vaccines for acute respiratory infections.

Authors:  I C Verma
Journal:  Indian J Pediatr       Date:  1987 Mar-Apr       Impact factor: 1.967

3.  Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Authors:  W S Pomat; D Lehmann; R C Sanders; D J Lewis; J Wilson; S Rogers; T Dyke; M P Alpers
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 4.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

5.  Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children.

Authors:  H Brüssow; M Baensch; J Sidoti
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

6.  Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.

Authors:  A E Fiore; O S Levine; J A Elliott; R R Facklam; J C Butler
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

7.  The late 1970s: a lull in the action on kuru.

Authors:  Phillip I Tarr
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.